Gauri Rao

UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill

Affiliated withUniversity of North Carolina, Chapel Hill University of North Carolina at Chapel Hill

Research Area

Biography

Gauri Rao has not added Biography.
If you are Gauri Rao and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title Cited by 3	2022
Publication title Cited by 5	2022

Other Publications

Article	Year
Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii. International journal of antimicrobial agents\| PubMed ID: 27449542	2016
Polymyxin B in combination with doripenem against heteroresistant Acinetobacter baumannii: pharmacodynamics of new dosing strategies. The Journal of antimicrobial chemotherapy\| PubMed ID: 27494922	2016
Polymyxin B in Combination with Rifampin and Meropenem against Polymyxin B-Resistant KPC-Producing Klebsiella pneumoniae. Antimicrobial agents and chemotherapy\| PubMed ID: 27872078	2017
Multi-scale model of drug induced adaptive resistance of Gram-negative bacteria to polymyxin B. PloS one\| PubMed ID: 28334005	2017
Critical Need for Clarity in Polymyxin B Dosing. Antimicrobial agents and chemotherapy\| PubMed ID: 28438796	2017
Assessment of Combined Polymyxin B and Minocycline Therapy against Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniae. Antimicrobial agents and chemotherapy\| PubMed ID: 28438930	2017
Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review. Annals of clinical microbiology and antimicrobials\| PubMed ID: 29178957	2017
Effect of polymyxin B-containing regimens on renal function for the treatment of carbapenem-resistant Enterobacteriacea mediastinitis. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases\| PubMed ID: 29182906	2018
Evaluation of Activity and Emergence of Resistance of Polymyxin B and ZTI-01 (Fosfomycin for Injection) against KPC-Producing Klebsiella pneumoniae. Antimicrobial agents and chemotherapy\| PubMed ID: 29203494	2018
Assessment and modelling of antibacterial combination regimens. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases\| PubMed ID: 29269090	2018
Validation of a Model Predicting Anti-infective Lung Penetration in the Epithelial Lining Fluid of Humans. Pharmaceutical research\| PubMed ID: 29368211	2018
Personalizing Polymyxin B Dosing Using an Adaptive Feedback Control Algorithm. Antimicrobial agents and chemotherapy\| PubMed ID: 29760144	2018
Comparison of the composition and in vitro activity of polymyxin B products. International journal of antimicrobial agents\| PubMed ID: 29807163	2018
Impact of Antibiotic Resistance on Treatment of Pneumococcal Disease in Ethiopia: An Agent-Based Modeling Simulation. The American journal of tropical medicine and hygiene\| PubMed ID: 31516111	2019
Development of a Minimal Physiologically-Based Pharmacokinetic Model to Simulate Lung Exposure in Humans Following Oral Administration of Ivermectin for COVID-19 Drug Repurposing. Journal of pharmaceutical sciences\| PubMed ID: 32891630	2020
A mechanism-based pharmacokinetic model of remdesivir leveraging interspecies scaling to simulate COVID-19 treatment in humans. CPT: pharmacometrics & systems pharmacology\| PubMed ID: 33296558	2021
Reapproaching Old Treatments: Considerations for PK/PD Studies on Phage Therapy for Bacterial Respiratory Infections. Clinical pharmacology and therapeutics\| PubMed ID: 33615463	2021
The Complex Roadmap to Infectious Disease Innovation: The Intersection of Bugs, Drugs, and Special Populations. Clinical pharmacology and therapeutics\| PubMed ID: 33769563	2021
Polymyxins for the treatment of lower respiratory tract infections: lessons learned from the integration of clinical pharmacokinetic studies and clinical outcomes. International journal of antimicrobial agents\| PubMed ID: 33785362	2021
Antibiotic pharmacokinetic/pharmacodynamic modelling: MIC, pharmacodynamic indices and beyond. International journal of antimicrobial agents\| PubMed ID: 34058336	2021
Insights Into Patient Variability During Ivacaftor-Lumacaftor Therapy in Cystic Fibrosis. Frontiers in pharmacology\| PubMed ID: 34408649	2021
Assessing the predictive performance of population pharmacokinetic models for intravenous polymyxin B in critically ill patients. CPT: pharmacometrics & systems pharmacology\| PubMed ID: 34811968	2021
Pharmacodynamic and immunomodulatory effects of polymyxin B in combination with fosfomycin against KPC-2-producing Klebsiella pneumoniae. International journal of antimicrobial agents\| PubMed ID: 35288260	2022
Knowledge dissemination and central indexing of resources in pharmacometrics: an ISOP education working group initiative. Journal of pharmacokinetics and pharmacodynamics\| PubMed ID: 35474412	2022
Clinical challenges treating infections: an update. JAC-antimicrobial resistance\| PubMed ID: 35529051	2022